The antiaggregatory effectiveness of PGI2 and its binding to specific platelet receptors. A comparative study.
Jaschonek
K
K
Medizinische Klinik, Universität Tübingen, FRG.
Renn
W
W
Weisenberger
H
H
D000244:Adenosine Diphosphate / Q000494:pharmacology; D001792:Blood Platelets / Q000187:drug effects / Q000502:physiology*; D003327:Coronary Disease / Q000097:blood*; D011464:Epoprostenol / Q000097:blood / Q000494:pharmacology*; D006801:Humans; D066298:In Vitro Techniques; D010974:Platelet Aggregation / Q000187:drug effects; D044006:Receptors, Epoprostenol; D011982:Receptors, Prostaglandin / Q000378:metabolism; D012016:Reference Values
D044006:Receptors, Epoprostenol; D011982:Receptors, Prostaglandin; D000244:Adenosine Diphosphate; D011464:Epoprostenol